Petra Märtens Person-Info 

( Ich bin Petra Märtens)

News

Study: 80% of US physicians use Herceptin for HER2-positive metastatic gastric ...

www.news-medical.net
[News-Medical.net] - "These results are surprising, especially when compared with satisfaction seen in other dynamic and difficult-to-treat indications, such as non-small cell lung cancer," said Petra Maertens, director of oncology syndicated studies for GfK HealthCare.
Dossier exportieren
+1